Drug Database
Back to search

Japan· JP-1329707Q1289

フルチカゾンプロピオン酸エステル

A fluticasone product containing フルチカゾンプロピオン酸エステル, registered in Japan by 三和化学研究所, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC R03BA05

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフルチカゾンプロピオン酸エステルATCR03BA05REGISTER NO.JP-1329707Q1289PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about フルチカゾンプロピオン酸エステルAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fluticasone is registered in 16 of 19 countries.

Countries holding a registration under ATC R03BA05 (fluticasone), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search fluticasone products by name

Fluticasone · ATC R03BA05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フルチカゾンプロピオン酸エステル
Manufacturer
三和化学研究所
Country
Japan (JP)
ATC code
R03BA05
ATC class
Fluticasone
Defined daily dose
0.6 mg, Inhal
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

576 interactions on record for fluticasone.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fluticasone against other medicinesHow interaction checks work

Fluticasone · interactions on record

576 records

  • 35 severe
  • 44 moderate
  • 20 minor
  • 475 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MifepristoneG03XB01severe
  • DesmopressinH01BA02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Flixonase Aquosum, Flixotide Diskus Forte
  • Belgium · Flixonase Aqua, Flixotide
  • Bulgaria · Аркуист, Фликсоназе
  • Cyprus · Cutivate, Flixonase Aqueous
  • Czechia · Flixotide Diskus, Flixotide Inhaler N
  • Germany · Flutica, Fluticason Cipla
  • Denmark · Flixotide, Flurhin
  • Estonia · Cutivate Cream, Flixonase
  • Spain · Avancort, Flixonase
  • Finland · Flixonase, Flixotide Diskus
  • France · Fixorinox, Flixonase
  • United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
  • Greece · Alerxem, Bocacort-S
  • Croatia · Flixonase, Flixotide Inhaler
  • Hungary · Cutivate, Flixonase
  • Ireland · Arquist, Flixonase Allergy Relief
  • Iceland · Avamys, Flixotide
  • Italy · Aktanos, Deflut
  • Liechtenstein · Avamys
  • Lithuania · Cutivate, Flixotide
  • Luxembourg · Flixonase Aqua, Flixotide
  • Latvia · Flixonase, Flixotide
  • Malta · Cutivate, Flihaler
  • Netherlands · Cortifil, Cutivate
  • Norway · Avamys, Flurhin
  • Poland · Cutivate, Fanipos
  • Portugal · Brisovent Diskus, Brisovent Inalador
  • Romania · Arquist, Cutivate
  • Sweden · Arquist, Fluticasone Cipla
  • Slovenia · Flixonase, Flixotide
  • Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f409c2ac-29fd-4bcc-ba97-83eb2ba7c903
GET /v1/drugs/f409c2ac-29fd-4bcc-ba97-83eb2ba7c903?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２．０４ｍｇ４ｍＬ１瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "1329707Q1289",
  "category": "外用薬",
  "price_yen": 283,
  "generic_name": "フルチカゾンプロピオン酸エステル",
  "product_name_jp": null,
  "therapeutic_class": "1329",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console